SCHEMBL4984084

SCHEMBL4984084

COC(=O)C(CS)NC(=O)C(=O)NC(CS)C(=O)OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.43
THRB P10828 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
ALOX15 P16050 1/20 0.43
NFKB1 P19838 1/20 0.43
PTGS2 P35354 1/20 0.43
THPO P40225 1/20 0.43
RECQL P46063 1/20 0.43
BLM P54132 1/20 0.43
ACE P12821 1/20 0.39
TGFBR1 P36897 1/20 0.39
HSD17B10 Q99714 2/20 0.37
TSHR P16473 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
ATM Q13315 1/20 0.33
FOLH1 Q04609 1/20 0.33
BIRC2 Q13490 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10505071 1.00 SMN1; SMN2 (0.43) SMN1; SMN2THRBKDM4EMAPTALOX15
SCHEMBL10951417 0.88 TGFBR1 (0.46) SMN1; SMN2THRBKDM4EMAPTALOX15
SCHEMBL10503056 0.87 HDAC1 (0.37) SMN1; SMN2THRBKDM4EMAPTALOX15
SCHEMBL2891328 0.86 TGFBR1 (0.50) SMN1; SMN2THRBKDM4EMAPTALOX15
SCHEMBL7924715 0.84 SMN1; SMN2 (0.42) SMN1; SMN2THRBKDM4EMAPTALOX15
SCHEMBL14088106 0.84 SMN1; SMN2 (0.63) SMN1; SMN2THRBKDM4EMAPTALOX15
SCHEMBL112331 0.84 SMN1; SMN2 (0.63) SMN1; SMN2THRBKDM4EMAPTALOX15
SCHEMBL1762251 0.84 THRB (0.47) SMN1; SMN2THRBKDM4EMAPTALOX15
SCHEMBL112332 0.84 SMN1; SMN2 (0.63) SMN1; SMN2THRBKDM4EMAPTALOX15
SCHEMBL5056684 0.84 SMN1; SMN2 (0.42) SMN1; SMN2THRBKDM4EMAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080138309-A1 Use Of Aminodithiol As A Reducing Agent For Hair Perming L'OREAL S.A. (FR) 2008-06-12 US claimed
EP-1844007-A1 USE OF AMINODITHIOL AS A REDUCING AGENT FOR HAIR PERMING L'Oréal (FR) 2007-10-17 EP claimed
WO-2006077170-A1 USE OF AMINODITHIOL AS A REDUCING AGENT FOR HAIR PERMING L'OREAL (FR) 2006-07-27 WO claimed
US-20080138309-A1 Use Of Aminodithiol As A Reducing Agent For Hair Perming L'OREAL S.A. (FR) 2008-06-12 US disclosed
EP-1844007-A1 USE OF AMINODITHIOL AS A REDUCING AGENT FOR HAIR PERMING L'Oréal (FR) 2007-10-17 EP disclosed
WO-2006077170-A1 USE OF AMINODITHIOL AS A REDUCING AGENT FOR HAIR PERMING L'OREAL (FR) 2006-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080138309-A1 Use Of Aminodithiol As A Reducing Agent For Hair Perming AASDHPPT, BHMT2, ALAD SMN1; SMN2 4833/4885THRB 3230/4885KDM4E 1902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.